Sectors

AMPH
Amphastar Pharmaceuticals, Inc.
19.80
1 x 19.89
1 x 19.95
bid
ask
+
0.21
1.08%
10:00 AM
timesize
Ytd-26.06%
1y-7.25%
19.68
day range
19.95
16.65
52 week range
31.26
Open19.71Prev Close19.59Low19.68High19.95Mkt Cap863.78M
Vol70.44KAvg Vol605.56KEPS2.93P/E6.69Forward P/E5.49
Beta0.89Short Ratio11.61Inst. Own75.56%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0650-d Avg19.20200-d Avg23.181yr Est31.29

AMPH News

benzinga.com
Amphastar Pharmaceuticals Unit International Medication Systems Receives FDA Warning Letter Regardin

On July 2, 2026, International Medication Systems, Limited ("IMS"), a subsidiary of the Comp

Crude Oil Gains 2%; Comcast Shares Spike Higher
benzinga.com
Crude Oil Gains 2%; Comcast Shares Spike Higher

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 200 poi

This Liquidia Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
benzinga.com
This Liquidia Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Top Wall Street analysts changed outlook on top stocks. See all changes including upgrades, downgrad

benzinga.com
B of A Securities Downgrades Amphastar Pharma to Underperform, Lowers Price Target to $20

B of A Securities analyst Jason Gerberry downgrades Amphastar Pharma (NASDAQ:AMPH) from Neutral t

New Strong Sell Stocks for June 23rd
zacks.com
New Strong Sell Stocks for June 23rd

ARR, AMTB and AMPH have been added to the Zacks Rank #5 (Strong Sell) List on June 23rd, 2026.

Amphastar Pharmaceuticals Pivots to Proprietary Drugs, Biosimilars for Growth
marketbeat.com
Amphastar Pharmaceuticals Pivots to Proprietary Drugs, Biosimilars for Growth

Amphastar Pharmaceuticals NASDAQ: AMPH is positioning itself for a broader shift from complex generi

Amphastar Pharmaceuticals, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
globenewswire.com
Amphastar Pharmaceuticals, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More

SAN DIEGO, June 08, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating whether Amphastar

Amphastar Pharmaceuticals Sees Generic Atrovent Fueling 2026 Growth Despite BAQSIMI Drag
marketbeat.com
Amphastar Pharmaceuticals Sees Generic Atrovent Fueling 2026 Growth Despite BAQSIMI Drag

Amphastar Pharmaceuticals NASDAQ: AMPH executives told investors at the Jefferies Healthcare Confere

benzinga.com
Barclays Maintains Equal-Weight on Amphastar Pharma, Lowers Price Target to $20

Barclays analyst Glen Santangelo maintains Amphastar Pharma (NASDAQ:AMPH) with a Equal-Weight and

Amphastar Pharmaceuticals to Present at the 2026 Jefferies Healthcare Conference
accessnewswire.com
Amphastar Pharmaceuticals to Present at the 2026 Jefferies Healthcare Conference

RANCHO CUCAMONGA, CA / ACCESS Newswire / May 27, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH

This Whirlpool Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
benzinga.com
This Whirlpool Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

Analysts downgraded DOCS, MWH, WHR, AMPH, and WIX and lowered price targets. See how analysts view t

benzinga.com
Wells Fargo Downgrades Amphastar Pharma to Equal-Weight, Lowers Price Target to $19

Wells Fargo analyst Benjamin Burnett downgrades Amphastar Pharma (NASDAQ:AMPH) from Overweight to

Amphastar Pharmaceuticals Tackles BAQSIMI Discount Pressure, Keeps Sales Outlook
marketbeat.com
Amphastar Pharmaceuticals Tackles BAQSIMI Discount Pressure, Keeps Sales Outlook

Amphastar Pharmaceuticals NASDAQ: AMPH executives said the company is taking steps to address rebate

Amphastar Pharmaceuticals, Inc. (AMPH) Presents at Bank of America Global Healthcare Conference 2026 Transcript
seekingalpha.com
Amphastar Pharmaceuticals, Inc. (AMPH) Presents at Bank of America Global Healthcare Conference 2026

Amphastar Pharmaceuticals, Inc. (AMPH) Presents at Bank of America Global Healthcare Conference 2026

benzinga.com
Piper Sandler Reiterates Neutral on Amphastar Pharma, Lowers Price Target to $21

Piper Sandler analyst David Amsellem reiterates Amphastar Pharma (NASDAQ:AMPH) with a Neutral and

12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

This HubSpot Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday
benzinga.com
This HubSpot Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday

Wall Street analysts changed outlook on top names. Check all changes on analyst ratings page. See wh

12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2026 Earnings Call Transcript
seekingalpha.com
Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2026 Earnings Call Transcript

Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2026 Earnings Call Transcript

Compared to Estimates, Amphastar (AMPH) Q1 Earnings: A Look at Key Metrics
zacks.com
Compared to Estimates, Amphastar (AMPH) Q1 Earnings: A Look at Key Metrics

Although the revenue and EPS for Amphastar (AMPH) give a sense of how its business performed in the

Amphastar Pharmaceuticals (AMPH) Q1 Earnings Lag Estimates
zacks.com
Amphastar Pharmaceuticals (AMPH) Q1 Earnings Lag Estimates

Amphastar Pharmaceuticals (AMPH) came out with quarterly earnings of $0.42 per share, missing the Za

benzinga.com
Amphastar Pharma Q1 Adj. EPS $0.42 Misses $0.70 Estimate, Sales $171.171M Miss $173.392M Estimate

Amphastar Pharma (NASDAQ:AMPH) reported quarterly earnings of $0.42 per share which missed the analy

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026
accessnewswire.com
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026

Net revenues of $171.2 million for the three months ended March 31, 2026 GAAP net income of $6.4 mil

Amphastar Pharmaceuticals to Present at the 2026 Bank of America Health Care Conference
accessnewswire.com
Amphastar Pharmaceuticals to Present at the 2026 Bank of America Health Care Conference

RANCHO CUCAMONGA, CA / ACCESS Newswire / May 6, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7, 2026
accessnewswire.com
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7, 2026

RANCHO CUCAMONGA, CA / ACCESS Newswire / April 30, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AM

AMPH vs. RDY: Which Stock Should Value Investors Buy Now?
zacks.com
AMPH vs. RDY: Which Stock Should Value Investors Buy Now?

Investors interested in stocks from the Medical - Generic Drugs sector have probably already heard o

Amphastar Pharmaceuticals (AMPH) Expected to Beat Earnings Estimates: Should You Buy?
zacks.com
Amphastar Pharmaceuticals (AMPH) Expected to Beat Earnings Estimates: Should You Buy?

Amphastar (AMPH) possesses the right combination of the two key ingredients for a likely earnings be

Are Investors Undervaluing Amphastar Pharmaceuticals (AMPH) Right Now?
zacks.com
Are Investors Undervaluing Amphastar Pharmaceuticals (AMPH) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and

Amphastar Pharmaceuticals to Present at the 25th Annual Needham Healthcare Conference
accessnewswire.com
Amphastar Pharmaceuticals to Present at the 25th Annual Needham Healthcare Conference

RANCHO CUCAMONGA, CA / ACCESS Newswire / April 6, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMP

SG Americas Securities LLC Makes New Investment in Amphastar Pharmaceuticals, Inc. $AMPH
defenseworld.net
SG Americas Securities LLC Makes New Investment in Amphastar Pharmaceuticals, Inc. $AMPH

SG Americas Securities LLC purchased a new stake in Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) i

Amphastar Pharmaceuticals (NASDAQ:AMPH) Share Price Passes Below Two Hundred Day Moving Average   – Should You Sell?
defenseworld.net
Amphastar Pharmaceuticals (NASDAQ:AMPH) Share Price Passes Below Two Hundred Day Moving Average –

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH - Get Free Report)'s share price crossed below its two

Amphastar Pharmaceuticals, Inc. (AMPH) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
seekingalpha.com
Amphastar Pharmaceuticals, Inc. (AMPH) Presents at Barclays 28th Annual Global Healthcare Conference

Amphastar Pharmaceuticals, Inc. (AMPH) Presents at Barclays 28th Annual Global Healthcare Conference

Earnings Scheduled For February 26, 2026
benzinga.com
Earnings Scheduled For February 26, 2026

Earnings Scheduled For November 6, 2025
benzinga.com
Earnings Scheduled For November 6, 2025

benzinga.com
Earnings Scheduled For August 7, 2025

benzinga.com
Earnings Scheduled For May 7, 2025

benzinga.com
Earnings Scheduled For February 27, 2025

benzinga.com
Earnings Scheduled For February 28, 2024

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a

benzinga.com
Earnings Scheduled For May 9, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn

benzinga.com
64 Biggest Movers From Yesterday

Gainers  

benzinga.com
32 Stocks Moving In Monday's Mid-Day Session

Gainers FGI Industries Ltd. (NASDAQ: FGI) shares jumped 42.4% to $5.37 after surging 19% on Frida

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

Stocks That Hit 52-Week Lows On Thursday

benzinga.com
Stocks That Hit 52-Week Lows On Monday

Stocks That Hit 52-Week Lows On Monday

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

Stocks That Hit 52-Week Lows On Thursday

benzinga.com
Stocks That Hit 52-Week Lows On Friday

Stocks That Hit 52-Week Lows On Friday

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

Stocks That Hit 52-Week Lows On Thursday